Heprin 25000IU Injection
Prescription Required
Product introduction
Heprin 25000IU Injection is an anticoagulant which prevents abnormal clotting of blood. It not only prevents the formation of harmful blood clots in the legs, lungs, and heart but also stops them from growing bigger.
Heprin 25000IU Injection belongs to a group of medicines called anticoagulants. It affects the blood flow in the vessels. It is effective medicine used to treat blood clots that have formed abnormally inside the blood vessels. It makes your blood flow more easily.
Heprin 25000IU Injection belongs to a group of medicines called anticoagulants. It affects the blood flow in the vessels. It is effective medicine used to treat blood clots that have formed abnormally inside the blood vessels. It makes your blood flow more easily.
Uses of Heprin Injection
- Prevention of Blood clots
Benefits of Heprin Injection
In Prevention of Blood clots
Formation of blood clots blocks one or more veins, usually in your legs. Heprin 25000IU Injection is used to prevent formation of blood clots near the surface of your skin. It dissolves the clots and also relieves pain and inflammation by increasing the blood flow. This improves the overall healing process.
Heprin 25000IU Injection is given as an injection by the doctor and should not be self-administered. The condition usually improves on its own in some time. Additionally, the doctor might recommend applying heat to the painful area, elevating the affected leg, using an over-the-counter painkiller and possibly wearing compression stockings.
Heprin 25000IU Injection is given as an injection by the doctor and should not be self-administered. The condition usually improves on its own in some time. Additionally, the doctor might recommend applying heat to the painful area, elevating the affected leg, using an over-the-counter painkiller and possibly wearing compression stockings.
Side effects of Heprin Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youโre worried about them
Common side effects of Heprin
- Bleeding
- Erythema (skin redness)
How to use Heprin Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Heprin 25000IU Injection.
Pregnancy
CONSULT YOUR DOCTOR
Heprin 25000IU Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Heprin 25000IU Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Heprin 25000IU Injection is released in small amounts in the breast milk and amounts reaching the baby are also small, which would not be expected to cause any harmful effects to the baby.
Heprin 25000IU Injection is released in small amounts in the breast milk and amounts reaching the baby are also small, which would not be expected to cause any harmful effects to the baby.
Driving
SAFE
Heprin 25000IU Injection does not usually affect your ability to drive.
Kidney
SAFE IF PRESCRIBED
Heprin 25000IU Injection is safe to use in patients with kidney disease. No dose adjustment of Heprin 25000IU Injection is recommended.
However, inform your doctor if you have any underlying kidney disease.
However, inform your doctor if you have any underlying kidney disease.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Heprin 25000IU Injection in patients with liver disease. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Heprin 25000IU Injection
โน212.0/Injection
Heparin 25000IU Injection
Gland Pharma Limited
โน188.3/injection
11% cheaper
Caprin 25000IU Injection
Samarth Life Sciences Pvt Ltd
โน339/injection
60% costlier
Hep 25 Injection
Gland Pharma Limited
โน317/injection
50% costlier
V Parin 25000IU Injection
Vhb Life Sciences Inc
โน217.55/injection
3% costlier
Celparin 25000IU Injection
Celon Laboratories Ltd
โน296.15/injection
40% costlier
Quick tips
- Notify your doctor if you see blood in your urine or stool or any unusual bleeding from your skin, gums or nose.
- Inform your doctor if you experience rash, itching, swelling of the face, tongue, and throat while you receive this medicine.
Fact Box
Chemical Class
Sulfur-Rich Glycosaminoglycan
Habit Forming
No
Therapeutic Class
BLOOD RELATED
Action Class
Unfractionated Heparin (UFH)
Patient concerns
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Weitz JI. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmanโs: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 853-59.
- Zehnder JL. Drugs Used in Disorders of Coagulation. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 591-93.
- Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 367-73.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 652-53.
Marketer details
Name: Medilife Healthcare
Address: 412 E-Square, Subash Road, Vile Parle East, Mumbai - 400057
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
โน212
Inclusive of all taxes
1.0 Injection in 1 vial
SOLD OUT